1 Min Read
Nov 27 (Reuters) - Novartis AG:
* SANDOZ RECEIVES EIGHTH EUROPEAN COMMISSION APPROVAL FOR A BIOSIMILAR WITH ZIEXTENZO® (PEGFILGRASTIM) Source text for Eikon: Further company coverage: (Reporting by Berlin Speed Desk)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.